Connection

TAO WU to Neoplasm Staging

This is a "connection" page, showing publications TAO WU has written about Neoplasm Staging.
Connection Strength

0.426
  1. Risk-adapted survival benefit of IMRT in early-stage NKTCL: a multicenter study from the China Lymphoma Collaborative Group. Blood Adv. 2018 09 25; 2(18):2369-2377.
    View in: PubMed
    Score: 0.111
  2. Anlotinib combined with benmelstobart as a chemo-free first-line treatment in advanced esophageal squamous cell carcinoma: an exploratory multicenter, single-arm phase II clinical trial. Mol Cancer. 2025 Jun 11; 24(1):175.
    View in: PubMed
    Score: 0.044
  3. TNMpBC-NeoBCSS model: a breast cancer specific survival prediction model for triple-negative metaplastic breast carcinoma patients with neoadjuvant therapy. Sci Rep. 2025 Mar 11; 15(1):8351.
    View in: PubMed
    Score: 0.044
  4. Tislelizumab and radiation therapy in low-risk early-stage extranodal natural killer/T-cell lymphoma, nasal type: a phase II study protocol. Future Oncol. 2024 Feb; 20(5):245-256.
    View in: PubMed
    Score: 0.040
  5. Outcome and risk prediction of early progression in patients with extranodal natural killer/T cell lymphoma from the CLCG study. Ann Hematol. 2023 Sep; 102(9):2459-2469.
    View in: PubMed
    Score: 0.039
  6. First-line non-anthracycline-based chemotherapy for extranodal nasal-type NK/T-cell lymphoma: a retrospective analysis from the CLCG. Blood Adv. 2020 07 14; 4(13):3141-3153.
    View in: PubMed
    Score: 0.032
  7. Validation of nomogram-revised risk index and comparison with other models for extranodal nasal-type NK/T-cell lymphoma in the modern chemotherapy era: indication for prognostication and clinical decision-making. Leukemia. 2021 01; 35(1):130-142.
    View in: PubMed
    Score: 0.031
  8. Effect of age as a continuous variable on survival outcomes and treatment selection in patients with extranodal nasal-type NK/T-cell lymphoma from the China Lymphoma Collaborative Group (CLCG). Aging (Albany NY). 2019 10 06; 11(19):8463-8473.
    View in: PubMed
    Score: 0.030
  9. Risk-Dependent Conditional Survival and Failure Hazard After Radiotherapy for Early-Stage Extranodal Natural Killer/T-Cell Lymphoma. JAMA Netw Open. 2019 03 01; 2(3):e190194.
    View in: PubMed
    Score: 0.029
  10. Risk-dependent curability of radiotherapy for elderly patients with early-stage extranodal nasal-type NK/T-cell lymphoma: A multicenter study from the China Lymphoma Collaborative Group (CLCG). Cancer Med. 2018 12; 7(12):5952-5961.
    View in: PubMed
    Score: 0.028
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.